Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
|---|---|
| Enthalten in: |
European journal of internal medicine - 100(2022) vom: 28. Juni, Seite 140-142 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lambert, Catherine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 30.05.2022 Date Revised 30.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejim.2022.02.014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337130426 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337130426 | ||
| 003 | DE-627 | ||
| 005 | 20231225233717.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejim.2022.02.014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1123.xml |
| 035 | |a (DE-627)NLM337130426 | ||
| 035 | |a (NLM)35181184 | ||
| 035 | |a (PII)S0953-6205(22)00070-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lambert, Catherine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.05.2022 | ||
| 500 | |a Date Revised 30.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Humoral response | |
| 650 | 4 | |a Sars-cov-2 | |
| 650 | 4 | |a Therapeutic plasma exchange | |
| 650 | 4 | |a Vaccine | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Scohy, Anais |e verfasserin |4 aut | |
| 700 | 1 | |a Yombi, Jean Cyr |e verfasserin |4 aut | |
| 700 | 1 | |a Goffin, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Devresse, Arnaud |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of internal medicine |d 1997 |g 100(2022) vom: 28. Juni, Seite 140-142 |w (DE-627)NLM089689097 |x 1879-0828 |7 nnns |
| 773 | 1 | 8 | |g volume:100 |g year:2022 |g day:28 |g month:06 |g pages:140-142 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejim.2022.02.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 100 |j 2022 |b 28 |c 06 |h 140-142 | ||